Equine Healthcare Market Size, Share Report, Analysis, Trends, Growth 2032

The global Equine Healthcare market size accrued earnings worth approximately USD 2.58 Billion in 2023 and is predicted to gain revenue of about USD 4.40 Billion by 2032, is set to record a CAGR of nearly 6.1% over the period from 2024 to 2032.Request Free Sample

Equine Healthcare Market Overview

Equine has been used since long for transportation, warfare and farming purposes. Today, they are used as police horses, recreation, racing, and entertainment. Horse serum is used to develop a variety of vaccines and antitoxins to treat several infectious diseases including botulism, rabies, diphtheria, and infection from H5N1 influenza. Equine industry has greater economic effect in countries like United States, Australia, and New Zealand as they generate a huge amount of revenue. American Horse Council reveals that at present there are 9.2 million horses across the nation involving approximately 4.6 million people as horse owners, caretakers, employees, and volunteers.

Rising investments and popularity in alternative forms of gambling like horse racing, online gaming, betting, competitive riding, high return on investment and leisure is expected to drive the global equine healthcare market. Additionally, the growth initiatives by equine healthcare organizations to develop drugs for various diseases are expected to give impetus to the equine healthcare market.

Equine Healthcare Market: Report Scope

Additionally, the report includes the study of opportunities available in the equine healthcare market on a global level. In order to give the users of this report a comprehensive view on the equine healthcare market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product type segment, disease type segment and distribution channel segment are benchmarked based on their market size, growth rate, and general attractiveness. 

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research & development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.

Request Free Sample

The study provides a decisive view on the equine healthcare market by segmenting the market based on product type, disease type, by distribution channel and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

Based on product type the market is segmented into drug type, vaccine type, and supplemental feed additives.

Based on disease type the market is segmented into west nile virus, equine rabies, equine influenza, equine herpes virus, potomac horse fever and others category.

Based on distribution channel the market is segmented into veterinary hospitals and clinics, retail pharmacies and drug stores and others category.

The Australian market is among the leading horse breeding countries of Asia Pacific, hence contributing to the drastically increased demand for healthcare products in the Asia Pacific. Additionally, the maintenance of race-horse breeds by the rising investments from China by specific supplements, therapeutic and protection products is thriving the growth of Asia Pacific market globally. Also, according to a study conducted by the American Horse Council, U.S. has 9.2 million horses with $39 billion direct economic impacts. Also, a total 22,849 horses were imported into the U.S. in 2013, thereby increasing the demand of equine healthcare in North America.

The report also includes detailed profiles of end players such as

• Bayer AG (Bayer Animal Health)
• Boehringer Ingelheim
• Ceva Santé Animale
• Eli Lilly and Company (Elanco)
• Equine Products U.K. Ltd.
• Merck & Co. (Merck Animal Health)
• Sanofi (Merial)
• Purina Animal Nutrition LLC
• Vetoquinol S.A.
• Zoetis and Others.

This report segments the global equine healthcare market as follows:

Global Equine Healthcare Market: Product Type Segment Analysis

• Drug Type
  • Anti-Infectives
  • Anti-Inflammatory
  • Parasiticides
  • Others
• Vaccine Type
  • Inactivated
  • Live Attenuated
  • Recombinant
  • Others
• Supplemental Feed Additives

Global Equine Healthcare Market: Diseases Segment Analysis

• West Nile Virus
• Equine Rabies
• Equine Influenza
• Equine Herpes Virus 
• Potomac Horse Fever 
• Others

Global Equine Healthcare Market: Distribution Channel Method Analysis

• Veterinary Hospitals And Clinics
• Retail Pharmacies And Drug Stores
• Others

Global Equine Healthcare Market: Regional Segment Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa